| Predominant expression of Alzheimer’s disease-associated BIN1 in mature oligodendrocytes and localization to white matter tracts P De Rossi, V Buggia-Prévot, BLL Clayton, JB Vasquez, C Van Sanford, ... Molecular neurodegeneration 11, 1-21, 2016 | 118 | 2016 |
| Specific susceptibility to COVID-19 in adults with Down syndrome T Illouz, A Biragyn, M Frenkel-Morgenstern, O Weissberg, A Gorohovski, ... Neuromolecular medicine 23, 561-571, 2021 | 43 | 2021 |
| Ultrastructural and dynamic studies of the endosomal compartment in Down syndrome A Botté, J Lainé, L Xicota, X Heiligenstein, G Fontaine, A Kasri, I Rivals, ... Acta Neuropathologica Communications 8, 1-22, 2020 | 32 | 2020 |
| Immune dysregulation and the increased risk of complications and mortality following respiratory tract infections in adults with down syndrome T Illouz, A Biragyn, MF Iulita, L Flores-Aguilar, M Dierssen, I De Toma, ... Frontiers in immunology 12, 621440, 2021 | 29 | 2021 |
| Focusing on cellular biomarkers: The endo-lysosomal pathway in Down syndrome A Botté, MC Potier Progress in Brain Research 251, 209-243, 2020 | 20 | 2020 |
| Modifications of the endosomal compartment in fibroblasts from sporadic Alzheimer’s disease patients are associated with cognitive impairment L Xicota, J Lagarde, F Eysert, B Grenier-Boley, I Rivals, A Botté, S Forlani, ... Translational psychiatry 13 (1), 54, 2023 | 3 | 2023 |
| RIP Kinase 1 (RIPK1) modulates disease associated microglial response during demyelination S Goodwani, YL Lightfoot, BG Ford, O Calderon, M McReynolds, K Allton, ... Alzheimer's & Dementia 19, e077538, 2023 | | 2023 |
| Anti‐MS4A4A Antibody Modulates Myeloid Cell Biology and TREM2 Signaling YL Lightfoot, A Botte, RTP Trinh, GS Ding, M McReynolds, JK Allen, ... Alzheimer's & Dementia 19, e072144, 2023 | | 2023 |
| Correction: Predominant expression of Alzheimer’s disease-associated BIN1 in mature oligodendrocytes and localization to white matter tracts P De Rossi, V Buggia-Prévot, BLL Clayton, JB Vasquez, C van Sanford, ... Molecular neurodegeneration 18, 2023 | | 2023 |
| Correction to: Specific Susceptibility to COVID-19 in Adults with Down Syndrome I Tomer, B Arya, FM Milana, W Orly, G Alessandro, M Eugene, I Green, ... Neuromolecular Medicine 23 (4), 572-573, 2021 | | 2021 |
| Correction to: Specific Susceptibility to COVID-19 in Adults with Down Syndrome (NeuroMolecular Medicine,(2021), 10.1007/s12017-021-08651-5) T Illouz, A Biragyn, M Frenkel-Morgenstern, O Weissberg, A Gorohovski, ... NeuroMolecular Medicine, 2021 | | 2021 |
| Dysfonctionnements de la voie endo-lysosomale: de la trisomie 21 à la maladie d'Alzheimer A Botté Sorbonne université, 2019 | | 2019 |
| [P3–168]: GENETIC DISSECTION OF SEVERITY AND ONSET MODULATORS FOR ALZHEIMER's PATHOLOGY IN DOWN SYNDROME USING CELLULAR SYSTEMS A Murray, P Goh, YJ Yeap, C Startin, S Hamburg, R Hithersay, H d'Souza, ... Alzheimer's & Dementia 13 (7S_Part_20), P998-P999, 2017 | | 2017 |
| Modifications of the endo-lysosomal compartment in Down syndrome and Alzheimer’s disease: impact on amyloid deposition MC Potier, A Botté, J Lainé, A Franck, G Fontaine, J Lavaur European Neuropsychopharmacology 2 (26), S115, 2016 | | 2016 |
